A Dose Escalation Trial of Biweekly Docetaxel and Gemcitabine with Filgrastim or Pegfilgrastim for the Treatment of Patients with Advanced Solid Tumors
Year: 2010
Type: article
Study design: Clinical Trial
Source: Chemotherapy
DOI: 10.1159/000313526
Institutions: Dartmouth–Hitchcock Medical Center, Dartmouth Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Amgen, Dartmouth College
OpenAlex ID: W2051658454